# The Peregrine Post-Market Study for the Treatment of Hypertension

> **NCT02570113** · NA · COMPLETED · sponsor: **Ablative Solutions, Inc.** · enrollment: 45 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DEVICE:** Peregrine System Infusion Catheter

## Key facts

- **NCT ID:** NCT02570113
- **Lead sponsor:** Ablative Solutions, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2019-02
- **Final completion:** 2019-07
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02570113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02570113, "The Peregrine Post-Market Study for the Treatment of Hypertension". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02570113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*